<html><head><script id="decision-support-view" type="application/json">{
  "dsViewId": "Autonomiv_Neuropathy.v0",
  "language": {
    "originalLanguage": {
      "terminologyId": {
        "name": "ISO_639-1",
        "value": "ISO_639-1"
      },
      "codeString": "en"
    }
  },
  "decisionSupportViewDefinitions": {
    "en": {
      "name": "Autonomic Neuropathy (C3-Cloud)",
      "description": "To provide guidance about monitoring autonomic neuropathy in diabetes patients.\n"
    }
  },
  "resourceDescription": {
    "originalAuthor": {
      "date": "2017-07-09",
      "name": "Jimmy Axelsson",
      "organisation": "Cambio Healthcare Systems",
      "email": "models@cambiocds.com"
    },
    "otherContributors": [],
    "lifecycleState": "Author draft",
    "details": {
      "en": {
        "purpose": "To provide guidance about monitoring autonomic neuropathy in diabetes patients.",
        "keywords": [
          "Diabetes",
          "Abnormal sweating",
          "Diarrhoea",
          "Autonomic neuropathy",
          "Bladder problems"
        ],
        "use": "To identify diabetes patients in need of autonomic neuropathy monitoring. \n\nPatients are recommended to receive monitoring if they are experiencing:\n - Abnormal sweating\n - Unexplained diarrhoea, especially during the night\n - Unexplained bladder emptying problems\n - Loss of warning signs for hypoglycaemia",
        "copyright": "Â© Cambio Healthcare Systems"
      }
    },
    "otherDetails": {
      "references": "National Institute for Health and Clinical Excellence (2015) Type 2 diabetes in adults: management. NICE guideline (NG28).To identify diabetes patients in need of autonomic neuropathy monitoring. "
    }
  },
  "alertGuideIds": [],
  "executionGuideIds": [
    "Autonomic_Neuropathy"
  ],
  "alertBindings": {},
  "termDefinitions": {
    "en": {
      "id": "en",
      "terms": {}
    }
  },
  "resultTemplates": []
}</script></head><body></body></html>